恒瑞医药 港股通 空最新增减持 (2026-05-12) 官网 ( 01276.hk) | 44.44 | 5.63 | 0.37% (0.36%) | 上市时间2025-05-23股价61.35港币涨跌幅-1.68%成交金额2.01亿港币换手率0.05%市值4,071.92亿港币H股市值158.40亿港币总股本66.37亿H股本2.58亿每手股数200上市至今年化投资收益率13.51%港股通持仓占H股比例27.34% (43.10亿港币2026-05-20) 累计做空占H股比例11.43% (19.41亿港币2026-05-15) | |||
| 所属三级行业药品 (恒生) | 市盈率 | 26.43 | 市净率 | 2.48 | 股息率 | 1.39% (1.36%) | 恒生:医疗保健业药品及生物科技药品 |
| 所属指数指数纳入纳出 | |||||||
| 同股同权 | 查看历史折扣 | ||||||
| 备注 (4): | 双击编辑备注 |
恒瑞医药(01276) - 最新股东
*注解：（Ｌ）- 好仓, （Ｓ）- 淡仓, （Ｐ）- 可供借出的股份。
全部董事非董事
| 股东名称 | 持有权益的股份数目 | 占已发行的有投票权股份百分比 | 占股本比例 | 最后申报有关通知之日期 | 表格序号 |
|---|---|---|---|---|---|
| GIC Private Limited | 0.55% | 2026-04-01 | CS20260407E00021 | ||
| Morgan Stanley | 0.39% | 2026-04-03 | CS20260410E00191 | ||
| Morgan Stanley International Holdings Inc. | 0.32% | 2025-05-23 | CS20250528E00416 | ||
| JPMorgan Chase & Co. | 0.35% | 2026-05-18 | CS20260521E00320 | ||
| Wellington Management Group LLP | 0.35% | 2026-03-13 | CS20260316E00364 | ||
| The Capital Group Companies, Inc. | 0.34% | 2026-04-01 | CS20260403E00006 | ||
| Citigroup Inc. | 0.24% | 2026-04-30 | CS20260506E00474 | ||
| The Goldman Sachs Group, Inc. | 0.23% | 2025-11-24 | CS20251127E00348 | ||
| Boyu Capital Opportunities Master Fund | 0.19% | 2025-05-23 | CS20250605E00068 | ||
| 童小幪 | 0.21% | 2025-06-19 | IS20250624E00107 | ||
| UBS Group AG | 0.20% | 2025-12-22 | CS20251229E00291 | ||
| BNP PARIBAS SA | 0.20% | 2026-04-08 | CS20260413E00283 | ||
| Schroders PLC | 0.20% | 2026-05-12 | CS20260514E00009 | ||
| 楼丽广 (董事) | 0% | 2026-04-16 | DA20260428E00444 |